136 related articles for article (PubMed ID: 9245550)
21. Differential effects of CD4+ T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice.
O'Sullivan FX; Vogelweid CM; Besch-Williford CL; Walker SE
J Autoimmun; 1995 Apr; 8(2):163-75. PubMed ID: 7612146
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
[TBL] [Abstract][Full Text] [Related]
23. Cenerimod, a selective S1P
Gerossier E; Nayar S; Froidevaux S; Smith CG; Runser C; Iannizzotto V; Vezzali E; Pierlot G; Mentzel U; Murphy MJ; Martinic MM; Barone F
Arthritis Res Ther; 2021 Nov; 23(1):289. PubMed ID: 34839819
[TBL] [Abstract][Full Text] [Related]
24. Detection of Grb-2-related adaptor protein gene (GRAP) and peptide molecule in salivary glands of MRL/lpr mice and patients with Sjögren's syndrome.
Shiraiwa H; Takei M; Yoshikawa T; Azuma T; Kato M; Mitamura K; Ueki T; Kida A; Horie T; Seki N; Sawada S
J Int Med Res; 2004; 32(3):284-91. PubMed ID: 15174222
[TBL] [Abstract][Full Text] [Related]
25. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Akpek EK; Jabs DA; Gérard HC; Prendergast RA; Hudson AP; Lee B; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
[TBL] [Abstract][Full Text] [Related]
26. Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis.
Skarstein K; Nerland AH; Eidsheim M; Mountz JD; Jonsson R
Scand J Immunol; 1997 Oct; 46(4):373-8. PubMed ID: 9350288
[TBL] [Abstract][Full Text] [Related]
27. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis.
Igawa T; Nakashima H; Sadanaga A; Masutani K; Miyake K; Shimizu S; Takeda A; Hamano S; Yoshida H
Mod Rheumatol; 2009; 19(1):33-41. PubMed ID: 18779924
[TBL] [Abstract][Full Text] [Related]
28. Short-term administration of selected anti-T-cell receptor V beta chain specific MoAb reduces sialadenitis in MRL/lpr mice.
Skarstein K; Holmdahl R; Johannessen AC; Goldschmidt T; Jonsson R
Scand J Immunol; 1995 Nov; 42(5):529-34. PubMed ID: 7481557
[TBL] [Abstract][Full Text] [Related]
29. Sialadenitis in nonobese diabetic mice: transfer into syngeneic healthy neonates by splenic T lymphocytes.
Goillot E; Mutin M; Touraine JL
Clin Immunol Immunopathol; 1991 Jun; 59(3):462-73. PubMed ID: 2029797
[TBL] [Abstract][Full Text] [Related]
30. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice.
Hamano H; Saito I; Haneji N; Mitsuhashi Y; Miyasaka N; Hayashi Y
Eur J Immunol; 1993 Oct; 23(10):2387-91. PubMed ID: 8405038
[TBL] [Abstract][Full Text] [Related]
31. Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice.
Hasegawa H; Inoue A; Muraoka M; Yamanouchi J; Miyazaki T; Yasukawa M
Arthritis Res Ther; 2007; 9(1):R15. PubMed ID: 17284325
[TBL] [Abstract][Full Text] [Related]
32. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
33. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
34. McH-lpr/lpr-RA1 mice: A novel spontaneous mouse model of autoimmune sialadenitis.
Saito K; Mori S; Kodama T
Immunol Lett; 2021 Sep; 237():3-10. PubMed ID: 34174253
[TBL] [Abstract][Full Text] [Related]
35. Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci.
Kamao T; Miyazaki T; Soga Y; Komori H; Terada M; Ohashi Y; Nose M
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3257-65. PubMed ID: 19218603
[TBL] [Abstract][Full Text] [Related]
36. Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells.
Jonsson R; Tarkowski A; Bäckman K; Holmdahl R; Klareskog L
Immunology; 1987 Apr; 60(4):611-6. PubMed ID: 3294576
[TBL] [Abstract][Full Text] [Related]
37. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Burns WH; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
[TBL] [Abstract][Full Text] [Related]
38. Augmented levels of macrophage and Th1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis.
Mustafa W; Zhu J; Deng G; Diab A; Link H; Frithiof L; Klinge B
Clin Exp Immunol; 1998 Jun; 112(3):389-96. PubMed ID: 9649206
[TBL] [Abstract][Full Text] [Related]
39. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance.
Nishihara M; Terada M; Kamogawa J; Ohashi Y; Mori S; Nakatsuru S; Nakamura Y; Nose M
Arthritis Rheum; 1999 Dec; 42(12):2616-23. PubMed ID: 10616009
[TBL] [Abstract][Full Text] [Related]
40. Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide.
Li B; Wang F; Schall N; Muller S
J Autoimmun; 2018 Jun; 90():132-145. PubMed ID: 29486915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]